IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $40,870 | +16.0% | 901 | +4.9% | 0.00% | – |
Q2 2023 | $35,245 | +24.4% | 859 | +8.3% | 0.00% | – |
Q1 2023 | $28,342 | -5.8% | 793 | -0.5% | 0.00% | – |
Q4 2022 | $30,103 | -14.0% | 797 | 0.0% | 0.00% | – |
Q3 2022 | $35,000 | +29.6% | 797 | +7.8% | 0.00% | – |
Q2 2022 | $27,000 | 0.0% | 739 | 0.0% | 0.00% | – |
Q1 2022 | $27,000 | +22.7% | 739 | +1.1% | 0.00% | – |
Q4 2021 | $22,000 | +2100.0% | 731 | +4200.0% | 0.00% | – |
Q3 2021 | $1,000 | 0.0% | 17 | 0.0% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 17 | 0.0% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 17 | 0.0% | 0.00% | – |
Q4 2020 | $1,000 | 0.0% | 17 | 0.0% | 0.00% | – |
Q3 2020 | $1,000 | 0.0% | 17 | 0.0% | 0.00% | – |
Q2 2020 | $1,000 | 0.0% | 17 | -29.2% | 0.00% | – |
Q1 2020 | $1,000 | 0.0% | 24 | 0.0% | 0.00% | – |
Q4 2019 | $1,000 | – | 24 | +242.9% | 0.00% | – |
Q3 2019 | $0 | – | 7 | 0.0% | 0.00% | – |
Q2 2019 | $0 | -100.0% | 7 | 0.0% | 0.00% | – |
Q1 2019 | $1,000 | 0.0% | 7 | -75.9% | 0.00% | – |
Q1 2018 | $1,000 | – | 29 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |